EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Polymeric immunoglobulin receptor in liver diseases: a double-edged sword with therapeutic potential at the gut–liver axis

Lihuang Su, Siyong Zhang, Tongtong Pan

International Immunopharmacology · 2026-12 · 190 · 117555

DOI: 10.1016/j.intimp.2026.117555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Lihuang Su und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejian…. Hauptthemen laut MEDLINE: Liver Diseases, Receptors, Polymeric Immunoglobulin, Liver. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The polymeric immunoglobulin receptor (pIgR) mediates the transepithelial transport of polymeric immunoglobulin A (IgA) and plays a central role in gut immune homeostasis. Its involvement in liver diseases has become increasingly evident with advances in our understanding of the gut-liver axis. This review synthesizes current evidence on the molecular structure and regulation of pIgR expression. It examines the functional heterogeneity of pIgR across viral hepatitis, alcohol-related liver disease, and metabolic dysfunction-associated steatotic liver disease, autoimmune liver diseases, and hepatocellular carcinoma. Current evidence suggests that pIgR can exert protective effects by preserving the intestinal barrier integrity; however, under specific pathological conditions, it may contribute to autoimmune responses and tumor progression. The present review further evaluates the potential of pIgR for clinical translation as a biomarker and therapeutic target, discusses its immunopharmacological potential, and identifies unresolved questions that may guide future investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver DiseasesReceptors, Polymeric ImmunoglobulinLiverHumansAnimalsIntestinal Barrier FunctionBiomarkers

Stichwörter der Autor:innen

BiomarkersGut–liver axisLiver diseasesPolymeric immunoglobulin receptorTherapeutic targets

Substanzen

Receptors, Polymeric ImmunoglobulinBiomarkers

Autor:innen und Institutionen

  • Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
  • Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China. Electronic address: zsy424920@gmail.com.
  • Wenzhou Key Laboratory of Interdisciplinary and Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China; Department of Geriatrics, The First Affiliated Hospi…

Förderung

  • Zhejiang Province Natural Science Foundation

Zitieren

APA

Su, L., Zhang, S., & Pan, T. (2026). Polymeric immunoglobulin receptor in liver diseases: a double-edged sword with therapeutic potential at the gut–liver axis. International Immunopharmacology, 190, 117555. https://doi.org/10.1016/j.intimp.2026.117555

Vancouver

Su L, Zhang S, Pan T. Polymeric immunoglobulin receptor in liver diseases: a double-edged sword with therapeutic potential at the gut–liver axis. International Immunopharmacology. 2026;190:117555. doi:10.1016/j.intimp.2026.117555

BibTeX
@article{Su2026,
  author = {Su, Lihuang and Zhang, Siyong and Pan, Tongtong},
  title = {Polymeric immunoglobulin receptor in liver diseases: a double-edged sword with therapeutic potential at the gut–liver axis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {190},
  pages = {117555},
  doi = {10.1016/j.intimp.2026.117555}
}
Kostenlos starten →